Correlation Between ASTELLAS PHARMA and Merck

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ASTELLAS PHARMA and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ASTELLAS PHARMA and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ASTELLAS PHARMA UNSPADR and Merck Co, you can compare the effects of market volatilities on ASTELLAS PHARMA and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ASTELLAS PHARMA with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of ASTELLAS PHARMA and Merck.

Diversification Opportunities for ASTELLAS PHARMA and Merck

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between ASTELLAS and Merck is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding ASTELLAS PHARMA UNSPADR and Merck Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck and ASTELLAS PHARMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ASTELLAS PHARMA UNSPADR are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck has no effect on the direction of ASTELLAS PHARMA i.e., ASTELLAS PHARMA and Merck go up and down completely randomly.

Pair Corralation between ASTELLAS PHARMA and Merck

Assuming the 90 days trading horizon ASTELLAS PHARMA UNSPADR is expected to under-perform the Merck. In addition to that, ASTELLAS PHARMA is 1.46 times more volatile than Merck Co. It trades about -0.01 of its total potential returns per unit of risk. Merck Co is currently generating about 0.02 per unit of volatility. If you would invest  9,329  in Merck Co on September 1, 2024 and sell it today you would earn a total of  371.00  from holding Merck Co or generate 3.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

ASTELLAS PHARMA UNSPADR  vs.  Merck Co

 Performance 
       Timeline  
ASTELLAS PHARMA UNSPADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Merck 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

ASTELLAS PHARMA and Merck Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ASTELLAS PHARMA and Merck

The main advantage of trading using opposite ASTELLAS PHARMA and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ASTELLAS PHARMA position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.
The idea behind ASTELLAS PHARMA UNSPADR and Merck Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA